Basal cell carcinoma clinical guideline
Guideline highlights
Stratification of basal cell carcinoma (BCC) in accordance with the National Comprehensive Cancer Network Guidelines is recommended, with the goal of providing the most clinically relevant stratification to guide management of BCC.
Optimal biopsy techniques are considered, with the aim of obtaining a biopsy permitting accurate diagnosis and management of BCC.
Surgical treatment modalities are reviewed, as surgery remains the cornerstone of BCC treatment.
Nonsurgical approaches (topicals, radiation therapy, photodynamic therapy) have lower cure rates than surgical treatment and should only be considered for low-risk BCC or if surgery is contraindicated.
As there are limited treatment options for metastatic disease, early and complete treatment is important.
Patients diagnosed with BCC should have annual checks for recurrence or other new primary skin cancer(s).
Full BCC guideline in JAAD
Read the basal cell carcinoma guidelineView the AAD guidelines disclaimer.
Are you a patient with skin cancer?
See our AAD skin cancer pages for information on how to treat and manage your skin cancer.
Find a Dermatologist
Member directory
AAD Learning Center
2026 AAD Innovation Academy
Need coding help?
Reduce burdens
Clinical guidelines
Why use AAD measures?
New insights
Physician wellness
Joining or selling a practice?
Promote the specialty
Advocacy priorities